Edition:
United States

BTG PLC (BTG.L)

BTG.L on London Stock Exchange

552.00GBp
11:53am EDT
Change (% chg)

1.00 (+0.18%)
Prev Close
551.00
Open
554.00
Day's High
559.00
Day's Low
547.50
Volume
688,399
Avg. Vol
936,953
52-wk High
784.00
52-wk Low
467.40

Chart for

About

BTG plc is medical device development and healthcare service provider. It provides Interventional Medicine therapies for liver cancer, emphysema and vascular disorders, specialty pharmaceuticals for acute care and licensing business. It operates through three segments: Interventional Medicine, Specialty Pharmaceuticals and... (more)

Overall

Beta: 0.30
Market Cap(Mil.): £2,132.99
Shares Outstanding(Mil.): 387.11
Dividend: --
Yield (%): --

Financials

  BTG.L Industry Sector
P/E (TTM): -- 30.14 32.45
EPS (TTM): -0.06 -- --
ROI: -2.22 12.95 12.63
ROE: -2.24 14.92 14.80

Deals of the day-Mergers and acquisitions

Sept 7 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Friday:

Sep 07 2018

British healthcare firm BTG buys Irish vascular device maker

British healthcare company BTG Plc has acquired Irish medical device maker Novate Medical, adding to its portfolio a vascular device for managing blood clots.

Sep 07 2018

CORRECTED-British healthcare firm BTG buys Irish vascular device maker

Sept 7 British healthcare company BTG Plc has acquired Irish medical device maker Novate Medical, adding to its portfolio a vascular device for managing blood clots.

Sep 07 2018

Brazil court acquits former BTG Pactual CEO Esteves

SAO PAULO, July 12 A Brazilian federal judge on Thursday acquitted Banco BTG Pactual SA's founder and main partner André Esteves in a corruption probe, according to court documents.

Jul 12 2018

BTG owes Wellstat $55.8 mln in drug contract dispute: Delaware top court

The Delaware Supreme Court has upheld a decision requiring British pharmaceutical company BTG Plc to pay $55.8 million plus interest to Wellstat Therapeutics Corp for failing to properly market the latter's chemotherapy overexposure antidote.

Jun 12 2018

Earnings vs. Estimates